Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-4055 in Platinum Resistant Ovarian Cancer
NCT00831636Phase 2Completed
- Sponsor
- Clavis Pharma
- Start
- Apr 2008
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of elacytarabine in ovarian cancer, sponsored by Clavis Pharma. Started Apr 2008; status: completed.
02
Drugs
elacytarabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00831636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831636.